Skip to content

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

MOVE Corvex, Inc. Common Stock
$8.77 -4.88% -0.45
Notify me if price changes either direction
Interactive Brokers Logotype

Buy MOVE stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades
Loading

Key Stats

Market cap. 242.5M
Enterprise value 582.9M
Trailing PE -0.78757237669184
Forward PE -3.1148648
PEG Ratio -0.006706248174729
Enterprise to EBITDA -141.824
Enterprise to revenue 78.706
Price to book MRQ 0.033748586674028
Price to sales TTM 34.41914

Financials

Fiscal Year Ends 2025-12-31
Most Recent Quarter (MRQ) 2026-03-31
Revenue (TTM) 7.4M
EBITDA -4110000
Diluted EPS TTM -13.23
Total Cash (MRQ) 29.3M
Current ratio (MRQ) 2.144
Operating Cash Flow (TTM) -4008000

MOVE trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
$0 0 sells
$0 0 buys
In the last 0 months
Home

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.